nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Nucleoside Analog—Azathioprine—multiple sclerosis	0.733	1	CiPCiCtD
Ganciclovir—SLC22A1—Cladribine—multiple sclerosis	0.0815	0.5	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—multiple sclerosis	0.0401	0.246	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—multiple sclerosis	0.0245	0.15	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—multiple sclerosis	0.017	0.104	CbGbCtD
Ganciclovir—Valganciclovir—SLC15A2—multiple sclerosis	0.00192	0.569	CrCbGaD
Ganciclovir—Valaciclovir—SLC15A2—multiple sclerosis	0.00145	0.431	CrCbGaD
Ganciclovir—Anaphylactic shock—Methylprednisolone—multiple sclerosis	6.31e-05	0.000627	CcSEcCtD
Ganciclovir—Arrhythmia—Prednisone—multiple sclerosis	6.28e-05	0.000624	CcSEcCtD
Ganciclovir—Infection—Triamcinolone—multiple sclerosis	6.28e-05	0.000624	CcSEcCtD
Ganciclovir—Sweating—Methotrexate—multiple sclerosis	6.28e-05	0.000624	CcSEcCtD
Ganciclovir—Infection—Methylprednisolone—multiple sclerosis	6.27e-05	0.000623	CcSEcCtD
Ganciclovir—Haematuria—Methotrexate—multiple sclerosis	6.24e-05	0.00062	CcSEcCtD
Ganciclovir—Insomnia—Prednisolone—multiple sclerosis	6.22e-05	0.000618	CcSEcCtD
Ganciclovir—Alopecia—Prednisone—multiple sclerosis	6.22e-05	0.000618	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Methotrexate—multiple sclerosis	6.19e-05	0.000615	CcSEcCtD
Ganciclovir—Hypersensitivity—Mitoxantrone—multiple sclerosis	6.18e-05	0.000614	CcSEcCtD
Ganciclovir—Paraesthesia—Prednisolone—multiple sclerosis	6.18e-05	0.000614	CcSEcCtD
Ganciclovir—Tachycardia—Triamcinolone—multiple sclerosis	6.17e-05	0.000613	CcSEcCtD
Ganciclovir—Mental disorder—Prednisone—multiple sclerosis	6.16e-05	0.000612	CcSEcCtD
Ganciclovir—Nausea—Azathioprine—multiple sclerosis	6.16e-05	0.000612	CcSEcCtD
Ganciclovir—Tachycardia—Methylprednisolone—multiple sclerosis	6.16e-05	0.000612	CcSEcCtD
Ganciclovir—Skin disorder—Methylprednisolone—multiple sclerosis	6.13e-05	0.000609	CcSEcCtD
Ganciclovir—Malnutrition—Prednisone—multiple sclerosis	6.12e-05	0.000608	CcSEcCtD
Ganciclovir—Hyperhidrosis—Triamcinolone—multiple sclerosis	6.11e-05	0.000607	CcSEcCtD
Ganciclovir—Agranulocytosis—Methotrexate—multiple sclerosis	6.11e-05	0.000607	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methylprednisolone—multiple sclerosis	6.1e-05	0.000606	CcSEcCtD
Ganciclovir—Convulsion—Dexamethasone—multiple sclerosis	6.09e-05	0.000605	CcSEcCtD
Ganciclovir—Convulsion—Betamethasone—multiple sclerosis	6.09e-05	0.000605	CcSEcCtD
Ganciclovir—Hypertension—Dexamethasone—multiple sclerosis	6.07e-05	0.000603	CcSEcCtD
Ganciclovir—Hypertension—Betamethasone—multiple sclerosis	6.07e-05	0.000603	CcSEcCtD
Ganciclovir—Asthenia—Mitoxantrone—multiple sclerosis	6.01e-05	0.000598	CcSEcCtD
Ganciclovir—Myalgia—Betamethasone—multiple sclerosis	5.99e-05	0.000595	CcSEcCtD
Ganciclovir—Myalgia—Dexamethasone—multiple sclerosis	5.99e-05	0.000595	CcSEcCtD
Ganciclovir—Anxiety—Betamethasone—multiple sclerosis	5.97e-05	0.000593	CcSEcCtD
Ganciclovir—Anxiety—Dexamethasone—multiple sclerosis	5.97e-05	0.000593	CcSEcCtD
Ganciclovir—Discomfort—Dexamethasone—multiple sclerosis	5.91e-05	0.000588	CcSEcCtD
Ganciclovir—Discomfort—Betamethasone—multiple sclerosis	5.91e-05	0.000588	CcSEcCtD
Ganciclovir—Haemoglobin—Methotrexate—multiple sclerosis	5.91e-05	0.000587	CcSEcCtD
Ganciclovir—Hypotension—Methylprednisolone—multiple sclerosis	5.9e-05	0.000586	CcSEcCtD
Ganciclovir—Pain—Prednisolone—multiple sclerosis	5.88e-05	0.000584	CcSEcCtD
Ganciclovir—Haemorrhage—Methotrexate—multiple sclerosis	5.88e-05	0.000584	CcSEcCtD
Ganciclovir—Hepatitis—Methotrexate—multiple sclerosis	5.88e-05	0.000584	CcSEcCtD
Ganciclovir—Pharyngitis—Methotrexate—multiple sclerosis	5.83e-05	0.00058	CcSEcCtD
Ganciclovir—Urinary tract disorder—Methotrexate—multiple sclerosis	5.81e-05	0.000577	CcSEcCtD
Ganciclovir—Vision blurred—Prednisone—multiple sclerosis	5.77e-05	0.000573	CcSEcCtD
Ganciclovir—Urethral disorder—Methotrexate—multiple sclerosis	5.76e-05	0.000573	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	5.76e-05	0.000573	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	5.75e-05	0.000571	CcSEcCtD
Ganciclovir—Oedema—Betamethasone—multiple sclerosis	5.74e-05	0.00057	CcSEcCtD
Ganciclovir—Oedema—Dexamethasone—multiple sclerosis	5.74e-05	0.00057	CcSEcCtD
Ganciclovir—Anaphylactic shock—Dexamethasone—multiple sclerosis	5.74e-05	0.00057	CcSEcCtD
Ganciclovir—Anaphylactic shock—Betamethasone—multiple sclerosis	5.74e-05	0.00057	CcSEcCtD
Ganciclovir—Diarrhoea—Mitoxantrone—multiple sclerosis	5.74e-05	0.00057	CcSEcCtD
Ganciclovir—Insomnia—Triamcinolone—multiple sclerosis	5.72e-05	0.000568	CcSEcCtD
Ganciclovir—Insomnia—Methylprednisolone—multiple sclerosis	5.71e-05	0.000567	CcSEcCtD
Ganciclovir—Infection—Betamethasone—multiple sclerosis	5.7e-05	0.000566	CcSEcCtD
Ganciclovir—Infection—Dexamethasone—multiple sclerosis	5.7e-05	0.000566	CcSEcCtD
Ganciclovir—Ill-defined disorder—Prednisone—multiple sclerosis	5.68e-05	0.000565	CcSEcCtD
Ganciclovir—Paraesthesia—Triamcinolone—multiple sclerosis	5.68e-05	0.000564	CcSEcCtD
Ganciclovir—Feeling abnormal—Prednisolone—multiple sclerosis	5.67e-05	0.000563	CcSEcCtD
Ganciclovir—Paraesthesia—Methylprednisolone—multiple sclerosis	5.67e-05	0.000563	CcSEcCtD
Ganciclovir—Visual impairment—Methotrexate—multiple sclerosis	5.67e-05	0.000563	CcSEcCtD
Ganciclovir—Anaemia—Prednisone—multiple sclerosis	5.66e-05	0.000562	CcSEcCtD
Ganciclovir—Dyspnoea—Triamcinolone—multiple sclerosis	5.64e-05	0.00056	CcSEcCtD
Ganciclovir—Agitation—Prednisone—multiple sclerosis	5.63e-05	0.000559	CcSEcCtD
Ganciclovir—Thrombocytopenia—Betamethasone—multiple sclerosis	5.62e-05	0.000558	CcSEcCtD
Ganciclovir—Thrombocytopenia—Dexamethasone—multiple sclerosis	5.62e-05	0.000558	CcSEcCtD
Ganciclovir—Tachycardia—Betamethasone—multiple sclerosis	5.6e-05	0.000556	CcSEcCtD
Ganciclovir—Tachycardia—Dexamethasone—multiple sclerosis	5.6e-05	0.000556	CcSEcCtD
Ganciclovir—Dyspepsia—Triamcinolone—multiple sclerosis	5.57e-05	0.000553	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—multiple sclerosis	5.56e-05	0.000552	CcSEcCtD
Ganciclovir—Dyspepsia—Methylprednisolone—multiple sclerosis	5.56e-05	0.000552	CcSEcCtD
Ganciclovir—Hyperhidrosis—Dexamethasone—multiple sclerosis	5.55e-05	0.000551	CcSEcCtD
Ganciclovir—Hyperhidrosis—Betamethasone—multiple sclerosis	5.55e-05	0.000551	CcSEcCtD
Ganciclovir—Malaise—Prednisone—multiple sclerosis	5.52e-05	0.000549	CcSEcCtD
Ganciclovir—Vertigo—Prednisone—multiple sclerosis	5.5e-05	0.000547	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—multiple sclerosis	5.48e-05	0.000545	CcSEcCtD
Ganciclovir—Anorexia—Dexamethasone—multiple sclerosis	5.47e-05	0.000544	CcSEcCtD
Ganciclovir—Anorexia—Betamethasone—multiple sclerosis	5.47e-05	0.000544	CcSEcCtD
Ganciclovir—Urticaria—Prednisolone—multiple sclerosis	5.46e-05	0.000543	CcSEcCtD
Ganciclovir—Fatigue—Triamcinolone—multiple sclerosis	5.45e-05	0.000542	CcSEcCtD
Ganciclovir—Fatigue—Methylprednisolone—multiple sclerosis	5.44e-05	0.000541	CcSEcCtD
Ganciclovir—Pain—Triamcinolone—multiple sclerosis	5.41e-05	0.000537	CcSEcCtD
Ganciclovir—Hypotension—Dexamethasone—multiple sclerosis	5.36e-05	0.000533	CcSEcCtD
Ganciclovir—Hypotension—Betamethasone—multiple sclerosis	5.36e-05	0.000533	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—multiple sclerosis	5.33e-05	0.00053	CcSEcCtD
Ganciclovir—Vomiting—Mitoxantrone—multiple sclerosis	5.33e-05	0.00053	CcSEcCtD
Ganciclovir—Convulsion—Prednisone—multiple sclerosis	5.31e-05	0.000527	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—multiple sclerosis	5.3e-05	0.000526	CcSEcCtD
Ganciclovir—Hypertension—Prednisone—multiple sclerosis	5.29e-05	0.000525	CcSEcCtD
Ganciclovir—Rash—Mitoxantrone—multiple sclerosis	5.29e-05	0.000525	CcSEcCtD
Ganciclovir—Dermatitis—Mitoxantrone—multiple sclerosis	5.28e-05	0.000525	CcSEcCtD
Ganciclovir—Chills—Methotrexate—multiple sclerosis	5.28e-05	0.000524	CcSEcCtD
Ganciclovir—Headache—Mitoxantrone—multiple sclerosis	5.25e-05	0.000522	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	5.23e-05	0.000519	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	5.23e-05	0.000519	CcSEcCtD
Ganciclovir—Arthralgia—Prednisone—multiple sclerosis	5.21e-05	0.000518	CcSEcCtD
Ganciclovir—Myalgia—Prednisone—multiple sclerosis	5.21e-05	0.000518	CcSEcCtD
Ganciclovir—Feeling abnormal—Triamcinolone—multiple sclerosis	5.21e-05	0.000518	CcSEcCtD
Ganciclovir—Feeling abnormal—Methylprednisolone—multiple sclerosis	5.2e-05	0.000517	CcSEcCtD
Ganciclovir—Anxiety—Prednisone—multiple sclerosis	5.2e-05	0.000516	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—multiple sclerosis	5.2e-05	0.000516	CcSEcCtD
Ganciclovir—Insomnia—Dexamethasone—multiple sclerosis	5.19e-05	0.000516	CcSEcCtD
Ganciclovir—Insomnia—Betamethasone—multiple sclerosis	5.19e-05	0.000516	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	5.18e-05	0.000514	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	5.16e-05	0.000513	CcSEcCtD
Ganciclovir—Paraesthesia—Dexamethasone—multiple sclerosis	5.15e-05	0.000512	CcSEcCtD
Ganciclovir—Paraesthesia—Betamethasone—multiple sclerosis	5.15e-05	0.000512	CcSEcCtD
Ganciclovir—Discomfort—Prednisone—multiple sclerosis	5.15e-05	0.000512	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—multiple sclerosis	5.15e-05	0.000512	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—multiple sclerosis	5.12e-05	0.000508	CcSEcCtD
Ganciclovir—Hypersensitivity—Prednisolone—multiple sclerosis	5.07e-05	0.000503	CcSEcCtD
Ganciclovir—Dyspepsia—Betamethasone—multiple sclerosis	5.05e-05	0.000502	CcSEcCtD
Ganciclovir—Dyspepsia—Dexamethasone—multiple sclerosis	5.05e-05	0.000502	CcSEcCtD
Ganciclovir—Urticaria—Triamcinolone—multiple sclerosis	5.02e-05	0.000499	CcSEcCtD
Ganciclovir—Urticaria—Methylprednisolone—multiple sclerosis	5.01e-05	0.000498	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—multiple sclerosis	5.01e-05	0.000498	CcSEcCtD
Ganciclovir—Body temperature increased—Triamcinolone—multiple sclerosis	5e-05	0.000497	CcSEcCtD
Ganciclovir—Anaphylactic shock—Prednisone—multiple sclerosis	5e-05	0.000497	CcSEcCtD
Ganciclovir—Oedema—Prednisone—multiple sclerosis	5e-05	0.000497	CcSEcCtD
Ganciclovir—Abdominal pain—Methylprednisolone—multiple sclerosis	4.99e-05	0.000496	CcSEcCtD
Ganciclovir—Decreased appetite—Dexamethasone—multiple sclerosis	4.99e-05	0.000496	CcSEcCtD
Ganciclovir—Decreased appetite—Betamethasone—multiple sclerosis	4.99e-05	0.000496	CcSEcCtD
Ganciclovir—Nausea—Mitoxantrone—multiple sclerosis	4.98e-05	0.000495	CcSEcCtD
Ganciclovir—Infection—Prednisone—multiple sclerosis	4.97e-05	0.000493	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.95e-05	0.000492	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.95e-05	0.000492	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—multiple sclerosis	4.95e-05	0.000492	CcSEcCtD
Ganciclovir—Fatigue—Dexamethasone—multiple sclerosis	4.95e-05	0.000492	CcSEcCtD
Ganciclovir—Fatigue—Betamethasone—multiple sclerosis	4.95e-05	0.000492	CcSEcCtD
Ganciclovir—Pain—Dexamethasone—multiple sclerosis	4.91e-05	0.000488	CcSEcCtD
Ganciclovir—Pain—Betamethasone—multiple sclerosis	4.91e-05	0.000488	CcSEcCtD
Ganciclovir—Tachycardia—Prednisone—multiple sclerosis	4.88e-05	0.000485	CcSEcCtD
Ganciclovir—Skin disorder—Prednisone—multiple sclerosis	4.85e-05	0.000482	CcSEcCtD
Ganciclovir—Hyperhidrosis—Prednisone—multiple sclerosis	4.83e-05	0.00048	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—multiple sclerosis	4.82e-05	0.000479	CcSEcCtD
Ganciclovir—Anorexia—Prednisone—multiple sclerosis	4.76e-05	0.000473	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—multiple sclerosis	4.75e-05	0.000472	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—multiple sclerosis	4.73e-05	0.00047	CcSEcCtD
Ganciclovir—Feeling abnormal—Betamethasone—multiple sclerosis	4.73e-05	0.00047	CcSEcCtD
Ganciclovir—Feeling abnormal—Dexamethasone—multiple sclerosis	4.73e-05	0.00047	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Betamethasone—multiple sclerosis	4.69e-05	0.000466	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	4.69e-05	0.000466	CcSEcCtD
Ganciclovir—Hypersensitivity—Triamcinolone—multiple sclerosis	4.66e-05	0.000463	CcSEcCtD
Ganciclovir—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.65e-05	0.000462	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—multiple sclerosis	4.62e-05	0.000459	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—multiple sclerosis	4.6e-05	0.000457	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—multiple sclerosis	4.58e-05	0.000455	CcSEcCtD
Ganciclovir—Urticaria—Dexamethasone—multiple sclerosis	4.56e-05	0.000453	CcSEcCtD
Ganciclovir—Urticaria—Betamethasone—multiple sclerosis	4.56e-05	0.000453	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	4.55e-05	0.000452	CcSEcCtD
Ganciclovir—Dizziness—Prednisolone—multiple sclerosis	4.55e-05	0.000452	CcSEcCtD
Ganciclovir—Asthenia—Triamcinolone—multiple sclerosis	4.54e-05	0.000451	CcSEcCtD
Ganciclovir—Abdominal pain—Dexamethasone—multiple sclerosis	4.54e-05	0.000451	CcSEcCtD
Ganciclovir—Body temperature increased—Betamethasone—multiple sclerosis	4.54e-05	0.000451	CcSEcCtD
Ganciclovir—Body temperature increased—Dexamethasone—multiple sclerosis	4.54e-05	0.000451	CcSEcCtD
Ganciclovir—Abdominal pain—Betamethasone—multiple sclerosis	4.54e-05	0.000451	CcSEcCtD
Ganciclovir—Asthenia—Methylprednisolone—multiple sclerosis	4.53e-05	0.00045	CcSEcCtD
Ganciclovir—Insomnia—Prednisone—multiple sclerosis	4.52e-05	0.000449	CcSEcCtD
Ganciclovir—Paraesthesia—Prednisone—multiple sclerosis	4.49e-05	0.000446	CcSEcCtD
Ganciclovir—Pruritus—Triamcinolone—multiple sclerosis	4.47e-05	0.000445	CcSEcCtD
Ganciclovir—Cough—Methotrexate—multiple sclerosis	4.47e-05	0.000444	CcSEcCtD
Ganciclovir—Pruritus—Methylprednisolone—multiple sclerosis	4.46e-05	0.000444	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—multiple sclerosis	4.43e-05	0.000441	CcSEcCtD
Ganciclovir—Dyspepsia—Prednisone—multiple sclerosis	4.4e-05	0.000437	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—multiple sclerosis	4.36e-05	0.000433	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—multiple sclerosis	4.36e-05	0.000433	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—multiple sclerosis	4.36e-05	0.000433	CcSEcCtD
Ganciclovir—Decreased appetite—Prednisone—multiple sclerosis	4.34e-05	0.000432	CcSEcCtD
Ganciclovir—Rash—Prednisolone—multiple sclerosis	4.34e-05	0.000431	CcSEcCtD
Ganciclovir—Dermatitis—Prednisolone—multiple sclerosis	4.33e-05	0.00043	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	4.33e-05	0.00043	CcSEcCtD
Ganciclovir—Diarrhoea—Methylprednisolone—multiple sclerosis	4.32e-05	0.000429	CcSEcCtD
Ganciclovir—Fatigue—Prednisone—multiple sclerosis	4.31e-05	0.000428	CcSEcCtD
Ganciclovir—Headache—Prednisolone—multiple sclerosis	4.31e-05	0.000428	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—multiple sclerosis	4.3e-05	0.000428	CcSEcCtD
Ganciclovir—Constipation—Prednisone—multiple sclerosis	4.27e-05	0.000425	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—multiple sclerosis	4.21e-05	0.000418	CcSEcCtD
Ganciclovir—Dizziness—Triamcinolone—multiple sclerosis	4.18e-05	0.000416	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—multiple sclerosis	4.18e-05	0.000415	CcSEcCtD
Ganciclovir—Dizziness—Methylprednisolone—multiple sclerosis	4.17e-05	0.000415	CcSEcCtD
Ganciclovir—Infection—Methotrexate—multiple sclerosis	4.15e-05	0.000412	CcSEcCtD
Ganciclovir—Feeling abnormal—Prednisone—multiple sclerosis	4.12e-05	0.000409	CcSEcCtD
Ganciclovir—Asthenia—Dexamethasone—multiple sclerosis	4.12e-05	0.000409	CcSEcCtD
Ganciclovir—Asthenia—Betamethasone—multiple sclerosis	4.12e-05	0.000409	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—multiple sclerosis	4.09e-05	0.000406	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Prednisone—multiple sclerosis	4.09e-05	0.000406	CcSEcCtD
Ganciclovir—Nausea—Prednisolone—multiple sclerosis	4.09e-05	0.000406	CcSEcCtD
Ganciclovir—Pruritus—Dexamethasone—multiple sclerosis	4.06e-05	0.000403	CcSEcCtD
Ganciclovir—Pruritus—Betamethasone—multiple sclerosis	4.06e-05	0.000403	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—multiple sclerosis	4.06e-05	0.000403	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—multiple sclerosis	4.04e-05	0.000401	CcSEcCtD
Ganciclovir—Vomiting—Triamcinolone—multiple sclerosis	4.02e-05	0.0004	CcSEcCtD
Ganciclovir—Vomiting—Methylprednisolone—multiple sclerosis	4.01e-05	0.000399	CcSEcCtD
Ganciclovir—Rash—Triamcinolone—multiple sclerosis	3.99e-05	0.000396	CcSEcCtD
Ganciclovir—Dermatitis—Triamcinolone—multiple sclerosis	3.98e-05	0.000396	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—multiple sclerosis	3.98e-05	0.000396	CcSEcCtD
Ganciclovir—Rash—Methylprednisolone—multiple sclerosis	3.98e-05	0.000395	CcSEcCtD
Ganciclovir—Dermatitis—Methylprednisolone—multiple sclerosis	3.98e-05	0.000395	CcSEcCtD
Ganciclovir—Urticaria—Prednisone—multiple sclerosis	3.97e-05	0.000394	CcSEcCtD
Ganciclovir—Headache—Triamcinolone—multiple sclerosis	3.96e-05	0.000394	CcSEcCtD
Ganciclovir—Headache—Methylprednisolone—multiple sclerosis	3.95e-05	0.000393	CcSEcCtD
Ganciclovir—Abdominal pain—Prednisone—multiple sclerosis	3.95e-05	0.000393	CcSEcCtD
Ganciclovir—Body temperature increased—Prednisone—multiple sclerosis	3.95e-05	0.000393	CcSEcCtD
Ganciclovir—Diarrhoea—Dexamethasone—multiple sclerosis	3.93e-05	0.00039	CcSEcCtD
Ganciclovir—Diarrhoea—Betamethasone—multiple sclerosis	3.93e-05	0.00039	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—multiple sclerosis	3.9e-05	0.000388	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.81e-05	0.000378	CcSEcCtD
Ganciclovir—Dizziness—Betamethasone—multiple sclerosis	3.79e-05	0.000377	CcSEcCtD
Ganciclovir—Dizziness—Dexamethasone—multiple sclerosis	3.79e-05	0.000377	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—multiple sclerosis	3.78e-05	0.000375	CcSEcCtD
Ganciclovir—Nausea—Triamcinolone—multiple sclerosis	3.76e-05	0.000373	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—multiple sclerosis	3.75e-05	0.000373	CcSEcCtD
Ganciclovir—Nausea—Methylprednisolone—multiple sclerosis	3.75e-05	0.000372	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—multiple sclerosis	3.72e-05	0.00037	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—multiple sclerosis	3.71e-05	0.000369	CcSEcCtD
Ganciclovir—Hypersensitivity—Prednisone—multiple sclerosis	3.68e-05	0.000366	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—multiple sclerosis	3.68e-05	0.000365	CcSEcCtD
Ganciclovir—Vomiting—Dexamethasone—multiple sclerosis	3.65e-05	0.000363	CcSEcCtD
Ganciclovir—Vomiting—Betamethasone—multiple sclerosis	3.65e-05	0.000363	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—multiple sclerosis	3.63e-05	0.000361	CcSEcCtD
Ganciclovir—Rash—Betamethasone—multiple sclerosis	3.62e-05	0.00036	CcSEcCtD
Ganciclovir—Rash—Dexamethasone—multiple sclerosis	3.62e-05	0.00036	CcSEcCtD
Ganciclovir—Dermatitis—Betamethasone—multiple sclerosis	3.62e-05	0.000359	CcSEcCtD
Ganciclovir—Dermatitis—Dexamethasone—multiple sclerosis	3.62e-05	0.000359	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.61e-05	0.000358	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—multiple sclerosis	3.6e-05	0.000358	CcSEcCtD
Ganciclovir—Headache—Dexamethasone—multiple sclerosis	3.6e-05	0.000357	CcSEcCtD
Ganciclovir—Headache—Betamethasone—multiple sclerosis	3.6e-05	0.000357	CcSEcCtD
Ganciclovir—Asthenia—Prednisone—multiple sclerosis	3.59e-05	0.000356	CcSEcCtD
Ganciclovir—Pain—Methotrexate—multiple sclerosis	3.57e-05	0.000355	CcSEcCtD
Ganciclovir—Pruritus—Prednisone—multiple sclerosis	3.54e-05	0.000351	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—multiple sclerosis	3.44e-05	0.000342	CcSEcCtD
Ganciclovir—Diarrhoea—Prednisone—multiple sclerosis	3.42e-05	0.00034	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—multiple sclerosis	3.42e-05	0.000339	CcSEcCtD
Ganciclovir—Nausea—Betamethasone—multiple sclerosis	3.41e-05	0.000339	CcSEcCtD
Ganciclovir—Nausea—Dexamethasone—multiple sclerosis	3.41e-05	0.000339	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—multiple sclerosis	3.32e-05	0.00033	CcSEcCtD
Ganciclovir—Dizziness—Prednisone—multiple sclerosis	3.3e-05	0.000328	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—multiple sclerosis	3.3e-05	0.000328	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—multiple sclerosis	3.3e-05	0.000328	CcSEcCtD
Ganciclovir—Vomiting—Prednisone—multiple sclerosis	3.18e-05	0.000316	CcSEcCtD
Ganciclovir—Rash—Prednisone—multiple sclerosis	3.15e-05	0.000313	CcSEcCtD
Ganciclovir—Dermatitis—Prednisone—multiple sclerosis	3.15e-05	0.000313	CcSEcCtD
Ganciclovir—Headache—Prednisone—multiple sclerosis	3.13e-05	0.000311	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—multiple sclerosis	3.08e-05	0.000306	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—multiple sclerosis	3e-05	0.000298	CcSEcCtD
Ganciclovir—Nausea—Prednisone—multiple sclerosis	2.97e-05	0.000295	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—multiple sclerosis	2.96e-05	0.000294	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—multiple sclerosis	2.86e-05	0.000284	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—multiple sclerosis	2.76e-05	0.000274	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—multiple sclerosis	2.66e-05	0.000264	CcSEcCtD
Ganciclovir—Rash—Methotrexate—multiple sclerosis	2.63e-05	0.000262	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—multiple sclerosis	2.63e-05	0.000261	CcSEcCtD
Ganciclovir—Headache—Methotrexate—multiple sclerosis	2.62e-05	0.00026	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—multiple sclerosis	2.48e-05	0.000246	CcSEcCtD
